FDA Inspection 1222377 — Homart Pharmaceuticals Pty. Ltd.
The FDA completed an inspection of Homart Pharmaceuticals Pty. Ltd. on Nov 10, 2023 in Rydalmere. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 2 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Nov 10, 2023
- Fiscal Year
- 2024
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Rydalmere (Australia)
Citations
| ID | CFR | Description |
|---|---|---|
| 18148 | 21 CFR 117.37 | Sanitary facilities and controls |
| 22703 | 21 CFR 117.135(a)(1) | Process preventive controls - Implement |